Titles and Roles
- Director, Division of Breast Imaging
- Emory Healthcare
- Professor, Department of Radiology
- Emory University School of Medicine
- Breast Cancer
- Research Program
- Discovery and Developmental Therapeutics
Dr. Cohen has been board certified in radiology since 1979 and has served as Oral Board Examiner for the American Board of Radiology in 2000, 2005, 2007, and 2009. He began practicing at Emory Healthcare in 2009 and is currently Director of Breast Imaging. Additional leadership roles include a seat on the editorial board of RadioGraphics Journal and former co-chairmanship of the New York Susan G. Coleman Foundation Board.
Dr. Cohen earned his Doctor of Medicine from the University of Texas in Gavelston, Texas, graduating first in his medical school class in 1974. He completed his internship at the Boston Children’s Hospital of Harvard Medical School in 1975 and remained in Boston to complete his residency in pediatrics at Beth Israel Deaconess Medical Center in 1979.
Dr. Cohen is a member of Alpha Omega Alpha Honor Medical Society and received a scholarship from the organization for graduating as valedictorian.
Dr. Cohen has earned a plethora of awards including the Lange Publisher’s Award, the Eugene L. Porter Memorial Award in Physiology, the Roche Award, Randall Award, the Upjon Achievement Award, the Editor’s Recognition with Distinction from the academic journal Radiology (2003, 2004, 2005, 2006, 2007, and Special Distinction in 2002). Dr. Cohen was also named a fellow of the American College of Radiology and the Society of Breast Imaging.
Dr. Cohen specializes in the research of emerging magnetic resonance imaging techniques and horizons for evaluating lesions of the breast. He presented on this subject to fellow researchers at the annual meeting of the Radiology Society of North America in Chicago in 2008. He was also a site Principal Investigator in the ACRIN multi-institutional trial, which validated digital mammography for breast cancer detection. Dr. Cohen's research currently centers on digital tomosynthesis and molecular breast imaging.